LDL and ApoB: Beyond "Bad Cholesterol," Why Particle Count Matters

LDL-C, often called "bad cholesterol," measures how much cholesterol is carried inside low-density lipoproteins. ApoB is a protein found on every atherosclerosis-causing lipoprotein particle, so it can be read as the total number of those particles. Both are linked to atherosclerosis risk, but in people with high triglycerides, diabetes or metabolic syndrome, there can be a gap: LDL looks normal while ApoB is high. There is no "normal" LDL that applies to everyone. Your target depends on your personal cardiovascular risk.
What do LDL and ApoB mean in the body?
Cholesterol doesn't dissolve in blood, so it has to ride in "vehicles" called lipoproteins. LDL is the fleet that delivers cholesterol around the body, and every vehicle carries one ApoB license plate.
LDL-C measures "how much cargo is on board." ApoB measures "how many vehicles are on the road." It's the vehicles themselves that get stuck in the artery wall and slowly form plaque, so more vehicles means higher risk. Most of the time, cargo and vehicle count line up. But some people have many small vehicles, each carrying less cargo, so LDL-C looks normal while ApoB is high.
Typical reference ranges
LDL targets depend on cardiovascular risk level. Below is a summary of the recommendations in the 2019 ESC/EAS dyslipidaemia guidelines:
| Cardiovascular risk level | LDL-C target (mg/dL) | ApoB target (mg/dL) |
|---|---|---|
| Very high risk | Below 55, and a reduction of at least 50% from baseline | Below 65 |
| High risk | Below 70, and a reduction of at least 50% from baseline | Below 80 |
| Moderate risk | Below 100 | Below 100 |
| Low risk | Below 116 | — |
Your risk level is assessed by a physician based on age, blood pressure, blood sugar, smoking, kidney function, family history and whether you already have cardiovascular disease. US and Taiwan guidelines, and individual labs, present reference values differently, so please go by your report and your physician's explanation. An LDL-C of 190 mg/dL or higher needs further evaluation by a physician, regardless of other factors.
Common causes of high or low levels
High
- Genetics: familial hypercholesterolemia
- A diet high in saturated and trans fats
- Low thyroid function
- Liver or kidney issues such as nephrotic syndrome or cholestasis
- Lower estrogen after menopause
- Certain medications
- High ApoB is also common with insulin resistance, high triglycerides and diabetes
Low
- Taking lipid-lowering medication
- Overactive thyroid
- Malnutrition, malabsorption or severe liver disease
- A small number of inherited traits
"In range" doesn't always mean "fine"
A standard checkup usually looks at whether LDL is above the reference value on the report. That's an important screening step. Functional medicine adds two more angles: targets and patterns.
The same LDL of 120 mg/dL means something completely different for a 30-year-old woman with no other risk factors than for a 50-year-old man who has diabetes and smokes. Another common pattern: LDL isn't high, but triglycerides are high, HDL is low and insulin is high. In that case ApoB may already be elevated. Looking at LDL, ApoB, triglycerides and inflammation markers together gives a better estimate of the real burden on your blood vessels.
Markers we look at alongside it
- Triglycerides and HDL: when TG is high, ApoB and LDL are more likely to diverge
- High-sensitivity C-reactive protein (hs-CRP): low-grade inflammation in the blood vessels
- Homocysteine: a research marker related to the health of the blood vessel lining
- Fasting insulin and HOMA-IR: the metabolic side
- Lp(a): a genetically determined lipoprotein. The ESC/EAS guidelines recommend that adults have it tested at least once in their lifetime
Everyday factors that affect this number
- Cut back on saturated and trans fats, and use more unsaturated oils
- Eat more soluble fiber, such as oats, beans and vegetables
- Weight loss and regular exercise often help with ApoB and triglycerides
- Quit smoking
- For people with a strong genetic component, lifestyle changes may only go so far. A physician needs to assess whether medication is needed
When to see a doctor soon
- LDL-C of 190 mg/dL or higher
- A first-degree relative who had a heart attack or stroke before age 55 (men) or 65 (women)
- Yellow patches or bumps on the eyelids, elbows or Achilles tendons
- Chest pain, chest tightness, shortness of breath, weakness on one side or slurred speech: seek medical care immediately
How does ĒSEN read LDL and ApoB?
ĒSEN physicians look at LDL, ApoB, triglycerides and inflammation markers together, alongside your family history, blood pressure and metabolic status, to assess your overall cardiovascular risk. When needed, we add functional medicine testing, which includes ApoB and Lp(a).
If the pattern points to metabolism or inflammation, your physician will explain how it connects to a slowing metabolism and chronic inflammation, and discuss our Weight & Metabolism Signature Program or a meal plan with our dietitian. Whether you need lipid-lowering medication is assessed and explained by your physician based on your risk.
This article is for general health information and is not a substitute for an individual assessment by a physician.
FAQ
What is the difference between LDL and ApoB?
What is a normal LDL level?
If my LDL is normal, do I still need an ApoB test?
If my LDL is high, is it because I eat too much meat and eggs?
Can I stop my cholesterol medication on my own?
- Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 2020;41(1):111-188.
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143.
- Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal. 2017;38(32):2459-2472.
This is health education information. It does not replace a physician's diagnosis; whether a treatment is right for you needs a physician's assessment.





